Mustang Bio, Inc. ( MBIO) - Key Metrics
MBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.14 | -$0.15 | -$0.15 |
| 2025Q4 | $0 | -$0.07 | -$0.24 | -$0.24 |
| 2025Q3 | $0 | -$0.07 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.13 | -$0.22 | -$0.22 |
MBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.10 |
| 2026Q1 | 0% | -1.30 |
| 2025Q4 | 0% | -3.33 |
| 2025Q3 | 0% | -5.07 |
| 2025Q2 | 0% | -1.84 |
MBIO
Price: $0.51
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 169948
Ebitda: -6.9 millionMarket Capitalization: 4.1 million